BE858031A - Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain - Google Patents

Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain

Info

Publication number
BE858031A
BE858031A BE180368A BE180368A BE858031A BE 858031 A BE858031 A BE 858031A BE 180368 A BE180368 A BE 180368A BE 180368 A BE180368 A BE 180368A BE 858031 A BE858031 A BE 858031A
Authority
BE
Belgium
Prior art keywords
manufacturing
preparation promoting
blood plasma
blood coagulation
human blood
Prior art date
Application number
BE180368A
Other languages
English (en)
French (fr)
Original Assignee
Immuno A G Fur Chemisch Medizi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno A G Fur Chemisch Medizi filed Critical Immuno A G Fur Chemisch Medizi
Publication of BE858031A publication Critical patent/BE858031A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
BE180368A 1976-08-30 1977-08-23 Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain BE858031A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Publications (1)

Publication Number Publication Date
BE858031A true BE858031A (fr) 1977-12-16

Family

ID=3585985

Family Applications (1)

Application Number Title Priority Date Filing Date
BE180368A BE858031A (fr) 1976-08-30 1977-08-23 Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain

Country Status (17)

Country Link
US (1) US4160025A (no)
AR (1) AR213861A1 (no)
AT (1) AT350726B (no)
BE (1) BE858031A (no)
CA (1) CA1079191A (no)
CH (1) CH635747A5 (no)
DE (1) DE2734821C3 (no)
DK (1) DK151932C (no)
ES (1) ES461918A1 (no)
FI (1) FI57421C (no)
FR (1) FR2362633A1 (no)
GB (1) GB1554051A (no)
HU (1) HU180816B (no)
LU (1) LU78024A1 (no)
NL (1) NL170922C (no)
NO (1) NO148142C (no)
SE (1) SE443511B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
WO1981002105A1 (en) * 1980-01-28 1981-08-06 Baxter Travenol Lab Therapeutic compositions & methods for manufacture and use
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
DE3172210D1 (en) * 1980-05-27 1985-10-17 Miles Lab Blood coagulation promoting product and process of preparing same
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
JPS5866054A (ja) * 1981-10-14 1983-04-20 Sekisui Chem Co Ltd 血液検査用容器
JPS58105064A (ja) * 1981-12-17 1983-06-22 Sekisui Chem Co Ltd 血液凝固促進剤
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
CA1330302C (en) * 1988-01-18 1994-06-21 Miroslav Rybak Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
ATE296109T1 (de) * 1996-03-20 2005-06-15 Baxter Ag Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
DE50311422D1 (de) * 2002-07-23 2009-05-28 Bio & Bio Licensing Sa Thrombingenerierfähige und thrombinhaltige pharmazeutische wirkstoffzubereitungen und arzneimittel
RS20050051A (en) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Pharmaceutical active ingredient preparation and medicaments that contain thrombin or have a thrombin-generating capacity
EP2305289A1 (en) 2009-09-16 2011-04-06 Bio-Products & Bio-Engineering Aktiengesellschaft Medicinal products for the treatment of blood coagulation disorders
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью
WO2024012853A1 (de) 2022-07-12 2024-01-18 Biomedizinische Forschung & Bio-Produkte AG Arzneimittel zur förderung der hämostase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
DD121793A1 (no) * 1975-07-17 1976-08-20
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process

Also Published As

Publication number Publication date
SE443511B (sv) 1986-03-03
DK151932B (da) 1988-01-18
NO148142B (no) 1983-05-09
ES461918A1 (es) 1978-12-16
DE2734821A1 (de) 1978-03-02
FI772408A (fi) 1978-03-01
FI57421B (fi) 1980-04-30
DE2734821B2 (de) 1980-11-06
NL170922C (nl) 1983-01-17
HU180816B (en) 1983-04-29
GB1554051A (en) 1979-10-17
ATA640576A (de) 1978-11-15
NO772978L (no) 1978-03-01
DK151932C (da) 1988-06-20
SE7707992L (sv) 1978-03-01
FI57421C (fi) 1980-08-11
CA1079191A (en) 1980-06-10
NL170922B (nl) 1982-08-16
DK384577A (da) 1978-03-01
DE2734821C3 (de) 1985-03-14
NO148142C (no) 1983-08-17
FR2362633B1 (no) 1981-06-12
FR2362633A1 (fr) 1978-03-24
AR213861A1 (es) 1979-03-30
NL7708872A (nl) 1978-03-02
CH635747A5 (de) 1983-04-29
US4160025A (en) 1979-07-03
AT350726B (de) 1979-06-11
LU78024A1 (no) 1978-01-11

Similar Documents

Publication Publication Date Title
BE858031A (fr) Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain
OA06368A (fr) Procédé de production d'une préparation de facteur antihémophilique à partir de plasma de sang humain.
FR2434629B1 (fr) Procede de fabrication d'un instrument medical, notamment d'un tube d'un catheter
IT8249249A0 (it) Procedimento per la fabbricazione di pannolini elasticizzati
RO77508A (ro) 796cedeu 7e5t9u 6bti5e9ea u5ui fi3a4e5t 7e5t9u sutu9i chi9u9gica3e
NO157245C (no) Fremgangsmaate ved fremstilling av et blodkoagulasjonsfremmende preparat paa basis av humanproteiner.
IT1115552B (it) Procedimento per l'eliminazione selettiva delle lipoproteine dal plasma o siero sanguigno
FR2340101A1 (fr) Oxygenateur et procede d'oxygenation du sang
BE865916A (fr) Procede de fabrication d'une electrode bipolaire
FR2591433B1 (fr) Procede de fabrication de fromages a pate molle
MX5405E (es) Metodo para separar el factor ix de coagulacion de la sangre a partir del plasma
RO73305A (ro) Procedeu pentru prepararea unor nitrili ai acidului tiazolilcinamic
BE895961A (fr) Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine
FR2621489B1 (fr) Appareil oxygenateur de sang
FR2591432B1 (fr) Procede de fabrication de fromages a pate persillee
FR2548538B1 (fr) Production d'interferon humain et procede pour le dosage de l'aptitude du sang a produire de l'interferon
ES486698A0 (es) Mejoras introducidas en la fabricacion de suturas quirurgi- cas elastomericas
FR2607808B1 (fr) Procede de preparation de trifluoromethylbenzonitrile a partir de trifluoromethylbenzaldehyde
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
FR2350335A1 (fr) Procede de preparation du sulfate de l'octapeptidamide de la cholecystokinine-pancreozymine
IT8267883A0 (it) Procedimento per la produzione di effettori fisiologici e loro impiego particolarmente per il controllodella coagulazione del sangue
FR2600078B1 (fr) Procede de preparation de facteur xiii a partir du placenta
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
FR2654091B1 (fr) Procede de fabrication d'analogues de l'alumine-beta.
FR2606772B1 (fr) Procede catalytique de fabrication de fluorure d'isobutyryle

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: IMMUNO A.G. FUR CHEMISCH-MEDIZINISCHE PRODUKTE

Effective date: 19970823